PacifiCord is a proud member of the HealthBanks Biotech family, a corporation that is a leader in the biotechnology research field. HealthBanks Biotech is well-regarded in the cord blood banking industry, with cord blood banking facilities in Taiwan, Hong Kong, Thailand, Macau, and Irvine. With this international experience, PacifiCord is able to be at the forefront of the industry in terms of the latest technology, the latest processing methods, and the needs of the general public.
PacifiCord and HealthBanks Biotech are happy to be partnered with some of the best research and development laboratories across the globe. Alongside Reber Genetics, Purzer Pharmaceutical Co., and TheVax, we have been able to create a great partnership that has put forward a nonstop effort to find potential treatments with the use of stem cells.
HealthBanks Biotech is not only a leader in the cord blood banking industry, but a leader in medical research as well. Because of our drive to provide premium care for all, HealthBanks has research and development teams located at UCLA, Princeton, Johns Hopkins, and in Taiwan. Because of our pursuit to provide more, PacifiCord and HealthBanks are very proud that we are in the middle of clinical trials for an HPV vaccine. This vaccine would be the first of its kind in a groundbreaking step in the treatment of cervical cancer.
In addition to the HPV (Human Papilloma Virus) vaccine, our research and development teams across the United States are working on different ways to expand the number of stem cells after initial collection. Because the success of a stem cell transplant is reliant on HLA tissue matching, stem cell viability, and the number of cells transplanted, it is important to make sure you have as large and pure a sample as possible.
PacifiCord is FDA registered and licensed by the State of California Department of Health which requires us to comply with the current AABB standards for cell therapy, California Health and Safety Code, California Business and Professional Code and California Code of Regulations. PacifiCord also has a license from the New York Department of Health for tissue operations.
PacifiCord has put together one of the top medical teams in the industry to ensure optimal processing and storage procedures for our clients. Our medical team features some of the leaders in the cord blood and stem cell world, which allows us to always be ahead of the game.
Learning all of the details surrounding cord blood banking, and about what matters concerning the processing and storage of your baby’s stem cells can be overwhelming. That is why parents can have peace of mind knowing that PacifiCord has the highest level of service, and has invested in the most optimal, state-the-art technology available, not just what is acceptable in the cord blood banking industry Read more
Learning all of the details surrounding cord blood banking, and about what matters concerning the processing and storage of your baby’s stem cells can be overwhelming. That is why parents can have peace of mind knowing that PacifiCord has the highest level of service, and has invested in the most optimal, state-the-art technology available, not just what is acceptable in the cord blood banking industry
PacifiCord has proudly invested in the same premium processing and storage technology as the world-leading cord blood banks known for successful transplants, including the New York Blood Center, Duke University, and M.D. Anderson. Our cord blood processing system, the AXP AutoXpress platform, provides the most precise cell separation and the highest published cell recoveries in the industry – important factors prior to storage. Storing your baby’s stem cells in the BioArchive, the leading storage system specifically designed for long-term preservation of only cord blood stem cells, is also a system adopted by over 29 countries, 76 institutions and over 60% of public banks worldwide.
When it comes to the quality and long-term viability of your baby’s stem cells, PacifiCord, focuses on what truly matters; adhering to global best practices. In association with five additional cord blood locations and three research and development subsidiaries worldwide, PacifiCord is a member of the HealthBanks Biotech family of companies, which for over 22 years has been a leader in pharmaceuticals, stem cell therapy, and research with thousands of cord blood procedures worldwide. In connection with our parent company, HealthBanks Biotech, PacifiCord invests millions of dollars in relevant research and development projects, including those involving umbilical cord blood stem cells, maintaining the focused goal to find cures for diseases and disabilities that are currently thought to be untreatable.
The PacifiCord team looks forward to providing your family with our cord blood banking services, along with our ongoing community outreach programs, such as our many free prenatal classes; complimentary facility tours offered seven days a week, free consultations, and our Cord Blood Concierge Service™.
In Good Health, H.K. Chang
With more than 40 years of experience in blood banking and transfusion medicine, Paul V. Holland, M.D. is a leading expert in the field. As PacifiCord’s Medical Director, Dr. Holland oversees the medical and laboratory procedures for PacifiCord’s cord blood banking operation. Read more
Dr. Holland also serves as a Clinical Professor of Medicine and Pathology in the Division of Hematology/Oncology and the Pathology Department at the University of California, Davis, Medical Center (UCDMC). Additionally he is the Scientific Director of Delta Blood Bank in Stockton, CA. Dr. Holland continues to be involved in research activities related to TRALI (transfusion related acute lung injury) as well as other transfusion-associated complications, and transfusion-transmitted infections. Dr. Holland was the Medical Director and Chief Executive Officer of the Sacramento Medical Foundation Blood Center (currently doing business as BloodSource) from 1983 to 2004. Dr. Holland started his career at the NIH Blood Bank Department in 1963, where he spent 20 years with this government organization, including nine years as Chief of the Blood Bank Department. Dr. Holland has more than 250 published papers in peer-reviewed scientific journals and books. He has served on multiple committees for the American Association of Blood Banks (AABB) and NIH, and has been an advisor to various U.S. government committees and agencies. As a consultant, he has aided numerous biotechnology companies, foreign governments and international organizations, among them the World Health Organization (WHO) that assists blood banks in third-world countries. Dr. Holland served two years as President of the International Society of Blood Transfusion (ISBT). He has been a nominating committee member for the Nobel Prize in Medicine and Physiology for three years. Dr. Holland is the recipient of numerous honors, including being an ISBT Lifetime Honorary Member and three awards from the AABB. In 2009, he will receive the Susan Leden Memorial Award from the California Blood Bank Society (CBBS). Dr. Holland received his BA in zoology at the University of California, Riverside, in 1958 followed by his MD at the University of California, Los Angeles, in 1962. In addition, he has performed post-graduate work in immunology, immunochemistry, genetics and virology at the NIH Foundation for Advanced Education in the Sciences and completed his internal medicine residency at UCSF. Dr. Holland currently resides in Walnut Creek, Calif., with his wife of 46 years. He has four children and six grandchildren. He enjoys tennis and photography.